263 related articles for article (PubMed ID: 32329856)
1. MicroRNA-548c-5p inhibits the proliferation of breast cancer cells through regulating Wnt/β-catenin signaling pathway.
He SZ; Wang Q
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3795-3804. PubMed ID: 32329856
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-9501 inhibits breast cancer proliferation and metastasis through regulating Wnt/β-catenin pathway.
Que LM; Yang XR; Zhang YC; Zhong H
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4337-4347. PubMed ID: 32373971
[TBL] [Abstract][Full Text] [Related]
3. DCLK1 promotes malignant progression of breast cancer by regulating Wnt/β-Catenin signaling pathway.
Wang YL; Li Y; Ma YG; Wu WY
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9489-9498. PubMed ID: 31773701
[TBL] [Abstract][Full Text] [Related]
4. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
Wang FH; Ma XJ; Xu D; Luo J
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling.
Jiang J; Yang X; He X; Ma W; Wang J; Zhou Q; Li M; Yu S
Chem Biol Interact; 2019 Apr; 302():74-82. PubMed ID: 30738779
[TBL] [Abstract][Full Text] [Related]
6. Cyclic RNA hsa_circ_0091017 inhibits proliferation, migration and invasiveness of bladder cancer cells by binding to microRNA-589-5p.
Zhang L; Xia HB; Zhao CY; Shi L; Ren XL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):86-96. PubMed ID: 31957821
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene.
Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-424-5p inhibits the development of non-small cell LCa by binding to ITGB1.
Xu ZL; Zhang M; Chen SX; Qiu M; Zhang Q; Gao LP; Li JDX
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8921-8930. PubMed ID: 31696479
[TBL] [Abstract][Full Text] [Related]
10. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667
[TBL] [Abstract][Full Text] [Related]
11. Male-specific long non-coding RNA testis-specific transcript, Y-linked 15 promotes gastric cancer cell growth by regulating Wnt family member 1/β-catenin signaling by sponging microRNA let-7a-5p.
Zheng X; Peng B; Wu X; Ye J; Zhao H; Li Y; Chen R; Gong X; Zhang H; Guo X
Bioengineered; 2022 Apr; 13(4):8605-8616. PubMed ID: 35287556
[TBL] [Abstract][Full Text] [Related]
12. MiRNA-221-5p promotes breast cancer progression by regulating E-cadherin expression.
Niu XY; Zhang ZQ; Ma PL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6983-6990. PubMed ID: 31486498
[TBL] [Abstract][Full Text] [Related]
13. LncRNA GIHCG regulates microRNA-1281 and promotes malignant progression of breast cancer.
Fan LY; Shi KY; Xu D; Ren LP; Yang P; Zhang L; Wang F; Shao GL
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10842-10850. PubMed ID: 31858553
[TBL] [Abstract][Full Text] [Related]
14. Downregulated lncRNA ADAMTS9-AS2 in breast cancer enhances tamoxifen resistance by activating microRNA-130a-5p.
Shi YF; Lu H; Wang HB
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1563-1573. PubMed ID: 30840279
[TBL] [Abstract][Full Text] [Related]
15. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
[TBL] [Abstract][Full Text] [Related]
16. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
[TBL] [Abstract][Full Text] [Related]
17. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
Yu XY; Tian JR; Yang D; Tan HR
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21.
Zhang Q; Miao S; Han X; Li C; Zhang M; Cui K; Xiong T; Chen Z; Wang C; Xu H
Cell Death Dis; 2018 Sep; 9(10):960. PubMed ID: 30237499
[TBL] [Abstract][Full Text] [Related]
19. miR-150-5p suppresses the stem cell-like characteristics of glioma cells by targeting the Wnt/β-catenin signaling pathway.
Tian W; Zhu W; Jiang J
Cell Biol Int; 2020 May; 44(5):1156-1167. PubMed ID: 32009256
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-1236-3p inhibits proliferation and invasion of breast cancer cells by targeting ZEB1.
Liang TC; Fu WG; Zhong YS
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9988-9995. PubMed ID: 31799668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
